Shephard Mpofu
Chief Tech/Sci/R&D Officer at ACELYRIN, INC.
Shephard Mpofu active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ACELYRIN, INC. | Chief Tech/Sci/R&D Officer | 2024-05-08 | - |
| Corporate Officer/Principal | 2023-10-02 | 2024-05-08 |
Career history of Shephard Mpofu
Former positions of Shephard Mpofu
| Companies | Position | Start | End |
|---|---|---|---|
| AVEXIS INC | Chief Tech/Sci/R&D Officer | - | - |
Training of Shephard Mpofu
| University of Zimbabwe | Undergraduate Degree |
Statistics
International
| United States | 3 |
| Zimbabwe | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ACELYRIN, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Stock Market
- Insiders
- Shephard Mpofu
- Experience
